Is ACADIA Pharmaceuticals Inc. (ACAD) a Buy, Sell, or Hold?
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$25.49 USD
-$0.01 (-0.04%)
- Volume
- 1.22M
- Average Volume
- 1.71M
- Market Capitalization
- $4.36B
- P/E Ratio
- 11.43
- Dividend Yield
- 0.00%
- Price Target
- $35.50
- Year High
- $28.35
- Year Low
- $19.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.59
Analyst Rating
Buy
4 Rating Score
UPSIDE/DOWNSIDE
-28.2% DOWNSIDE
$35.50 Price Target
UPSIDE/DOWNSIDE HIGH
-31.1% DOWNSIDE
$37.00 Price Target High
UPSIDE/DOWNSIDE LOW
-12.1% DOWNSIDE
$29.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Brian Abrahams | $36 | $25.77 | 2026-07-07 07:16 AM | 39.7% |
| Deutsche Bank | David Hoang | $37 | $25.0567 | 2026-06-29 08:52 AM | 47.7% |
| Canaccord Genuity | Sumant Kulkarni | $36 | $25.32 | 2026-06-29 07:00 AM | 42.2% |
| Wolfe Research | Rudy Li | $33 | $24.73 | 2026-02-23 04:18 PM | 33.4% |
| UBS | Ashwani Verma | $40 | $26.66 | 2026-01-06 08:38 AM | 50.0% |